Literature DB >> 9987635

Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids.

E A Bouzas1, P Moret, C J Pournaras.   

Abstract

BACKGROUND: Solar retinopathy and central serous chorio-retinopathy are two well-defined clinical entities which affect the macular area. Their association has never been described. The relation of central serous chorioretinopathy with the exposure to glucocorticoids has been recently suggested. CASE REPORT: Central serous chorioretinopathy developed in a patient who received corticosteroid therapy for solar retinopathy.
CONCLUSION: This case report provides additional evidence that central serous chorioretinopathy may develop under the effect of glucocorticoids. Retinal damage resulting from a previous insult, such as solar retinopathy, may act as the permissive factor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987635     DOI: 10.1007/s004170050213

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  Crohn's disease complicated by central serous retinopathy.

Authors:  G A Paspatis; P Koutentakis; K Triantafyllou; N Papanikolaoy; M Prinianaki; C Fanoyriakis
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Central serous chorioretinopathy: from glucocorticoids to light intensity.

Authors:  Amir Norouzpour; Majid Abrishami
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

3.  [Eclipse retinopathy : A case series after the partial solar eclipse on 20 March 2015].

Authors:  I Bachmeier; H Helbig; R Greslechner
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

4.  Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy.

Authors:  Fabio Mazzolani
Journal:  Clin Ophthalmol       Date:  2012-05-28

5.  Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy.

Authors:  Joseph Raevis; Eric Shrier
Journal:  Case Rep Ophthalmol       Date:  2017-03-07

6.  Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study.

Authors:  Fabio Mazzolani; Stefano Togni
Journal:  Clin Ophthalmol       Date:  2013-05-22

7.  Retinal and choroidal changes in steroid-associated central serous chorioretinopathy.

Authors:  Vikas Ambiya; Abhilash Goud; Mohammed Abdul Rasheed; Sankeert Gangakhedkar; Kiran Kumar Vupparaboina; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2018-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.